These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6865770)

  • 1. Cyclosporine: action, pharmacokinetics, and effect in the BB rat model.
    Stiller CR; Laupacis A; Keown PA; Gardell C; Dupre J; Thibert P; Wall W
    Metabolism; 1983 Jul; 32(7 Suppl 1):69-72. PubMed ID: 6865770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of cyclosporine protection against spontaneous diabetes mellitus in the BB/W or rat.
    Baquerizo H; Leone J; Pukel C; Wood P; Rabinovitch A
    J Autoimmun; 1989 Apr; 2(2):133-50. PubMed ID: 2669795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
    Takahashi K; Satoh J; Sagara M; Zhu XP; Muto G; Muto Y; Fukuzawa M; Nishimura S; Miyaguchi S; Toyata T
    J Autoimmun; 1995 Jun; 8(3):335-46. PubMed ID: 7575995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of silica prevents diabetes in BB-rats.
    Oschilewski U; Kiesel U; Kolb H
    Diabetes; 1985 Feb; 34(2):197-9. PubMed ID: 2981751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A.
    Like AA; Dirodi V; Thomas S; Guberski DL; Rossini AA
    Am J Pathol; 1984 Oct; 117(1):92-7. PubMed ID: 6385729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine pharmacokinetics and effect in the type I diabetic rat model.
    Brunner LJ; Iyer LV; Vadiei K; Weaver WV; Luke DR
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):287-92. PubMed ID: 2699289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline protects against diabetes in BB rats and potentiates cyclosporine protection.
    Rabinovitch A; Sumoski WL
    Diabetologia; 1990 Aug; 33(8):506-8. PubMed ID: 2210124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2-dependent control of disease development in spontaneously diabetic BB rats.
    Zielasek J; Burkart V; Naylor P; Goldstein A; Kiesel U; Kolb H
    Immunology; 1990 Feb; 69(2):209-14. PubMed ID: 2307481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat.
    Rossini AA; Faustman D; Woda BA; Like AA; Szymanski I; Mordes JP
    J Clin Invest; 1984 Jul; 74(1):39-46. PubMed ID: 6610693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclosporine on glucose tolerance in the rat.
    Yale JF; Roy RD; Grose M; Seemayer TA; Murphy GF; Marliss EB
    Diabetes; 1985 Dec; 34(12):1309-13. PubMed ID: 3905464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that cyclosporine prevents rejection and recurrent diabetes in pancreatic transplants in the BB rat.
    Dugoni WE; Bartlett ST
    Transplantation; 1990 May; 49(5):845-8. PubMed ID: 2336700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of diabetes in BB rats by intermittent administration of cyclosporine.
    Brayman KL; Armstrong J; Shaw LM; Rosano TG; Tomaszewski JE; Barker CF; Naji A
    Surgery; 1987 Aug; 102(2):235-41. PubMed ID: 3616913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of circulating immune complexes are not associated with diabetes in BB rats.
    Contreas G; Dyrberg T; Madsen OD; Markholst H; Lernmark A
    Diabetes Res; 1989 Mar; 10(3):109-13. PubMed ID: 2805585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unaltered class II histocompatibility antigens and pathogenesis of IDDM in BB rats.
    Holowachuk EW; Greer MK
    Diabetes; 1989 Feb; 38(2):267-71. PubMed ID: 2464510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to cyclosporine administration at onset of diabetes in BB rats.
    Yale JF; Grose M; Roy RD; Seemayer TA; Marliss EB
    Diabetes Res; 1987 Jul; 5(3):129-33. PubMed ID: 3311554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological and metabolic concomitants of cyclosporin prevention of diabetes in BB rats.
    Yale JF; Grose M; Seemayer TA; Marliss EB
    Diabetes; 1987 Jun; 36(6):749-57. PubMed ID: 3569673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical diabetes mellitus in the BB rat.
    Clarson C; Daneman D; Martin J
    Diabetes Res; 1986 Jun; 3(5):237-40. PubMed ID: 3527521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats.
    Satoh J; Shintani S; Oya K; Tanaka S; Nobunaga T; Toyota T; Goto Y
    Diabetes; 1988 Sep; 37(9):1188-94. PubMed ID: 3044884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratesticular islet xenograft survival in relation to tissue cyclosporine levels.
    Selawry HP; Whittington KB; Forster HG
    Am J Med Sci; 1988 Jun; 295(6):497-502. PubMed ID: 3133946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.